June 13, 2024
Dual Chamber Prefilled Syringes Market

The Rapid Growth of Dual Chamber Prefilled Syringes is Fuelled by Advances in Biologics

The dual chamber prefilled syringes market has witnessed significant growth in recent years driven by increasing demand for biologics which require separate drug and diluent storage. Dual chamber prefilled syringes provide distinct chambers for biologics and their diluents or solvents which are only mixed immediately prior to injection, ensuring the stability and potency of medicines. The convenience and ease of administration of these syringes compared to traditional vial and syringe systems have also increased their uptake.

 The Global dual chamber prefilled syringes market is estimated to be valued at US$ 171.8 Mn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2031.

The Dual Chamber Prefilled Syringes Market Size consist of two chambers—one for the biologic drug substance and the other for its solvent—separated by a common piston. This design allows biologics like monoclonal antibodies to be stored separately in a stable dry formulation until use while preventing any interaction between the drug and diluent. Upon injection, either a manually initiated or automated mixer mechanism ruptures the barrier between the chambers to mix the contents. This ensures biologics are reconstituted with no agitation or shaking immediately prior to injection, reducing dosing errors. The integrated design of dual chamber syringes also streamlines administration and lowers the risk of contamination compared to traditional vial systems.

Key Takeaways

Key players operating in the dual chamber prefilled syringes are Pfizer Inc., NIPRO PHARMA CORPORATION, Gerresheimer AG, Vetter Pharma, Credence MedSystems, Inc., ARTE Corporation, BD, MAEDA INDUSTRY Co., Ltd., Bayer, Stevanato Group, Elcam Drug Delivery Devices, SCHOTT Pharma, OndrugDelivery Ltd, Catalent, Inc, Dätwyler Holding Inc.

The growing popularity of biologic drugs along with advantages of dual chamber syringes like stability, ease of use and reduced contamination risks is fueling demand in the market.

Major players are undertaking mergers and acquisitions and expanding their manufacturing facilities globally especially in Asia Pacific and Europe to leverage the growth opportunities.

Market Key Trends

One of the key trends gaining traction in the Dual Chamber Prefilled Syringes Market Size is the development of smart connectable syringes that can enable digital connectivity and track usage data. For instance, Credence MedSystems is developing the Credence Smart Syringe platform with integrated sensors and electronics that can collect and share dosing information digitally. Such developments are expected to improve patient safety and drive prescription adherence. Furthermore, innovations focused on enhancing syringe ergonomics to facilitate easy mixing and dosing without agitation are also contributing to the demand for dual chamber prefilled syringes.

Porter’s Analysis

Threat of new entrants: New companies can enter this market with moderate investment in manufacturing facilities. However, established players have economies of scale and brand reputation advantage.

Bargaining power of buyers: Individual buyers have low bargaining power due to availability of alternative products. However, large pharma companies may avail volume discounts.

Bargaining power of suppliers: Few suppliers of glass containers and elastomeric components exist with differentiated products. Supplier concentration is balanced by availability of alternative suppliers.

Threat of new substitutes: Potential substitution threat comes from ready-to-use prefilled syringes. however, dual chamber syringes have inherent advantage of separating drug and diluent until use.

Competitive rivalry: Large multinational players dominate the market. Price and product quality competition is high among key players.

Geographical regions: North America leads the global market with over 40% share, driven by well-established healthcare systems and rising trends of self-administration of biologics. Asia Pacific is the fastest growing region supported by large patient pools, increasing access to healthcare, and growing biologics segment in major Asian countries.

The dual chamber prefilled syringes market in emerging economies of Latin America and Middle East & Africa is concentrated in urban centers and expected to witness highest CAGR over the forecast periodowing to healthcare infrastructure expansion, rising medical tourism, and growing demand for non-communicable disease therapies.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it